HLA-E and Miyoshi myopathy: These findings provide deeper insight into the molecular mechanisms underlying HLA-E regulation by RNA Pol I inhibitors and underscore promising combination therapeutic approaches with anti-MM agents aimed at augmenting NK cell-mediated responses against MM.